Glossary

Intended Use Statement

A formal declaration defining the general purpose of a medical device, including the disease or condition it diagnoses, treats, or prevents, serving as the foundation for FDA regulatory classification.

Get in touch Learn more

MLOps engineer reviewing model serving infrastructure on laptop, container orchestration visible, technical workspace.

REGULATORY DEFINITION

What is an Intended Use Statement?

A formal declaration defining the general purpose of a medical device, including the disease or condition it diagnoses, treats, or prevents.

An Intended Use Statement is a formal, legally binding declaration that defines the general purpose of a medical device, specifying the disease or condition it is designed to diagnose, treat, prevent, cure, or mitigate. It establishes the foundational scope for all subsequent regulatory submissions and clinical validation activities.

This statement is distinct from the more granular Indications for Use, which details the specific patient population, anatomical site, and clinical context. The Intended Use Statement drives the device's risk classification and determines the applicable FDA clearance pathway, such as a 510(k) or De Novo request.

REGULATORY ANATOMY

Core Components of an Intended Use Statement

An Intended Use Statement is a legally binding, formal declaration that defines the precise purpose of a medical device. It serves as the foundational boundary for all subsequent regulatory, clinical, and engineering decisions.

General Purpose Declaration

The opening clause that broadly defines the device's function. It must use specific verbs like diagnoses, treats, mitigates, or prevents to align with the FDA's definition of a medical device under section 201(h) of the FD&C Act.

Example: "The device is intended to analyze radiological images..."
Risk: Using vague terms like "assists" or "supports" without a clear medical objective can lead to classification ambiguity.
Origin: Derived directly from the statutory definition of a device.

Target Disease or Condition

A precise identification of the pathology, injury, or physiological state the device addresses. This component directly links the device to a specific medical claim.

Specificity is key: "Breast cancer" is insufficient; specify invasive ductal carcinoma or microcalcifications suspicious for malignancy.
Contraindications: The statement often implicitly or explicitly excludes conditions it is not validated for, defining the limits of the Indications for Use.
Regulatory Impact: This determines the clinical trial endpoints and the required patient population for validation.

Patient Population

Defines the demographic and clinical characteristics of the intended user group. This includes age range, sex, and specific clinical risk factors.

Example: "...for screening asymptomatic women aged 40-74 with dense breast tissue."
Pediatric vs. Adult: A clear distinction is critical, as pediatric devices face significantly higher regulatory scrutiny.
Inclusion/Exclusion Criteria: These boundaries are directly translated into the enrollment criteria for Clinical Validation Study Design.

Anatomical Site & Context

Specifies the exact body part and the clinical setting in which the device operates. This constrains the scope of the Analytical Validation.

Imaging Specificity: "...of the lung parenchyma in low-dose CT scans..." is far more precise than "...of chest images..."
Acquisition Protocol: Often implies the specific imaging modality (e.g., DICOM Standard Integration for mammography) and view (e.g., Craniocaudal, Mediolateral Oblique).
Environmental Context: Defines if the device is for emergency rooms, primary care, or Edge Deployment in ambulances.

Output & Clinical Action

Describes what the device produces and how a clinician should use that information. This distinguishes between Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx).

CADe: "...highlights regions of interest for review by a radiologist." The human makes the final call.
CADx: "...provides a malignancy likelihood score." The device contributes to the diagnostic decision.
Triage: "...prioritizes the worklist for STAT review." Defines a workflow automation role without direct diagnosis.
Critical Distinction: The level of automation here dictates whether a 510(k) or De Novo pathway is required.

User Profile

Identifies the intended operator, which is crucial for Human Factors Engineering (HFE) and labeling requirements.

Qualified Professionals: "...by a board-certified radiologist" implies specialized training is required.
Lay Users: If intended for patients at home, the statement must reflect this, triggering rigorous usability testing to prevent use-related errors.
Training Assumptions: The statement assumes a baseline competency, which must be validated during summative usability studies.

REGULATORY ESSENTIALS

Frequently Asked Questions

Clear answers to the most common questions about defining and documenting the intended use of Software as a Medical Device (SaMD).

An Intended Use Statement is a formal, legally binding declaration that defines the general purpose of a medical device, including the specific disease or condition it diagnoses, treats, or prevents. It serves as the cornerstone of the regulatory submission, establishing the boundaries for the FDA's evaluation of safety and effectiveness. This statement must precisely articulate the device's function, the target patient population, and the anatomical site or physiological process involved. It is distinct from Indications for Use, which further specifies the clinical context, such as the stage of disease or the specific type of clinician intended to use the device. A well-crafted statement is critical because it determines the device's classification, the required premarket pathway—such as a 510(k) Premarket Notification or De Novo Classification Request—and the scope of necessary clinical validation.

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.

Talk to Us

Intended Use Statement

What is an Intended Use Statement?